Leading the way from diagnostics to BiognostiX
27 Feb 2014 - 27 Feb 2014 - Hauser Forum, Cambridge, UK
The BiognostiX™ consortium, headed by experts at FFEI Life Science, has brought together academic, research and commercial partners from five European countries, and now the symposium ‘Leading the way from diagnostics to BiognostiX’, will feature presentations from each, accelerating the process of disseminating the proof of principle data generated as part of the project.
Using a multiplex microfluidic platform and newly invented Immuno-Ink™ BiognostiX will deliver revolutionary fast, flexible, single-use tests in a format that anyone can use. The desired biochemistry, microfluidics and a novel particle technology platform are combined on the BiognostiX Chip. Composed of a paper-based substrate, each BiognostiX Chip is mechanically treated to create a microfluidic channel pattern. Reagents are printed using fluid-jet technologies to deliver picolitre quantities of capture complex (Immuno-Ink) into specific zones of the channels enabling simultaneous performance of multiple tests per sample.
The simplicity and flexibility of the manufacturing process allows for changes in configuration during the assay development process.